Blackstone wants to be one of the leading investors in the future of biotechnology. And they’re just raised a historic new fund to do it.
What’s happening:
- Blackstone (NYSE: BX) has successfully raised $6.3B USD for their Blackstone Life Sciences VI fund
Why it matters:
- Blackstone’s new fund is the single largest private fund that has ever been raised for life sciences
Going deeper:
- Blackstone has publicly stated that their Blackstone Life Sciences VI Fund raised the majority of their capital from sovereign wealth funds, family offices, endowments and pension funds
- Since the initial launch of Blackstone’s life sciences platform less than a decade ago, Blackstone has raised more than $15B USD and helped directly finance over thirty new regulatory approvals for novel drugs and medical devices globally
